Spogen Biotech, Inc. – Trademark Portfolio
Entity Type: 03
Spogen Biotech, Inc. holds 27 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 24 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 12 trademarks are registered and 13 are pending. Notable registered marks include EE, RES+, AXION, FALCON, and VISMAX. The owner is based in St. Louis, MO.
1685 Galt Industrial Blvd.
St. Louis, MO 63132
Showing of trademarks Trademarks
Trademark Classifications
Spogen Biotech, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Spogen Biotech, Inc. have?
Spogen Biotech, Inc. has 27 U.S. trademarks filed with the USPTO. Of these, 12 registered, 13 pending, 1 abandoned, 1 cancelled.
What trademark classes does Spogen Biotech, Inc. file in?
Spogen Biotech, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 8 (Hand Tools). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Spogen Biotech, Inc.'s most well-known trademarks?
Spogen Biotech, Inc.'s registered trademark portfolio includes well-known marks such as EE, RES+, AXION, FALCON, and VISMAX. These are among 12 currently registered trademarks in the portfolio.
What is Spogen Biotech, Inc.'s trademark registration success rate?
Spogen Biotech, Inc. has a 86% trademark registration rate, with 12 out of 14 resolved applications resulting in successful registration. Currently, 13 applications are pending review.